🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Panbela Therapeutics, Inc.
Market Cap: Lowest
Employees: Lowest
SBP-101
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for treating various cancers, including pancreatic and ovarian cancers. Its lead product, SBP-101, is undergoing clinical trials for pancreatic cancer treatment.
Symbol: PBLA
Recent Price: $0.32
Industry: Biotechnology
CEO: Dr. Jennifer K. Simpson CRNP, M.S.N., Ph.D.
Sector: Healthcare
Employees: 7
Address: 712 Vista Boulevard, Waconia, MN 55387
Phone: 952 479 1196
Leadership
- Michael T. Cullen, MD, MBA, Chairman, President and Chief Executive Officer
- Jennifer K Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer
- Art Fratamico, MBA, Chief Business Officer
- Dan Donovan, CEO of rareLife Solutions, Inc.
- Jeff Mathiesen, Director and Audit Committee Chair
- Jeffrey Jacob, CEO at Cancer Prevention Pharmaceuticals, Inc.
- Robert Schemel, Director
- David Harle, Ph.D., Executive with over 25 years of pharmaceutical experience
- Mr. Donovan, CEO of rareLife Solutions, Inc.
Last updated: 2024-12-31